Authors:
Rozenbaum, W
Katlama, C
Massip, P
Bentata, M
Zucman, D
Delfraissy, JF
Trepo, C
David, F
Lanier, ER
Vavro, C
Mamet, JP
Citation: W. Rozenbaum et al., Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment, ANTIVIR TH, 6(2), 2001, pp. 135-142
Authors:
Meggetto, F
Cesarman, E
Mourey, L
Massip, P
Delsol, G
Brousset, P
Citation: F. Meggetto et al., Detection and characterization of human herpesvirus-8-infected cells in bone marrow biopsies of human immunodeficiency virus-positive patients, HUMAN PATH, 32(3), 2001, pp. 288-291
Authors:
Hance, AJ
Lemiale, V
Izopet, J
Lecossier, D
Joly, V
Massip, P
Mammano, F
Descamps, D
Brun-Vezinet, F
Clavel, F
Citation: Aj. Hance et al., Changes in human immunodeficiency virus type 1 populations after treatmentinterruption in patients failing antiretroviral therapy, J VIROLOGY, 75(14), 2001, pp. 6410-6417
Authors:
Bonnet, E
Ruidavets, JB
Tuech, J
Ferrieres, J
Collet, X
Fauvel, J
Massip, P
Perret, B
Citation: E. Bonnet et al., Apoprotein C-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: Association with the development of lipodystrophy, J CLIN END, 86(1), 2001, pp. 296-302
Authors:
Pellegrin, I
Segondy, M
Garrigue, I
Izopet, J
Montes, B
Pellegrin, JL
Reynes, J
Massip, P
Puel, J
Fleury, H
Citation: I. Pellegrin et al., Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy, J ACQ IMM D, 25(5), 2000, pp. 465-466
Authors:
Sailler, L
Marchou, B
Lemozy, J
Bonnet, E
Elias, Z
Cuzin, L
Massip, P
Citation: L. Sailler et al., Successful treatment of Actinobacillus actinomycetemcomitans endocarditis with ofloxacin, CL MICRO IN, 6(1), 2000, pp. 55-56
Authors:
Izopet, J
Massip, P
Souyris, C
Sandres, K
Puissant, B
Obadia, M
Pasquier, C
Bonnet, E
Marchou, B
Puel, J
Citation: J. Izopet et al., Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen, AIDS, 14(15), 2000, pp. 2247-2255
Authors:
Pasquier, C
Daudin, M
Righi, L
Berges, L
Thauvin, L
Berrebi, A
Massip, P
Puel, J
Bujan, L
Izopet, J
Citation: C. Pasquier et al., Sperm washing and virus nucleic acid detection to reduce HIV and hepatitisC virus transmission in serodiscordant couples wishing to have children, AIDS, 14(14), 2000, pp. 2093-2099
Authors:
Tamalet, C
Pasquier, C
Yahi, N
Colson, P
Poizot-Martin, I
Lepeu, G
Gallais, H
Massip, P
Puel, J
Izopet, J
Citation: C. Tamalet et al., Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection, J MED VIROL, 61(2), 2000, pp. 181-186
Authors:
Bicart-See, A
Massip, P
Linas, MD
Datry, A
Citation: A. Bicart-see et al., Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS, ANTIM AG CH, 44(1), 2000, pp. 167-168
Authors:
Reynes, J
Denisi, R
Massip, P
Izopet, J
Pellegrin, I
Segondy, M
Citation: J. Reynes et al., Once-daily administration of didanosine in combination with stavudine in antiretroviral-naive patients, J ACQ IMM D, 22(1), 1999, pp. 103-105
Authors:
Leclerc, C
Marchou, B
Sailler, L
Bonnet, E
Moron, M
Alcayde, S
Servat, M
Duchen, C
Hemery, C
Magnaval, JF
Massip, P
Citation: C. Leclerc et al., A new outbreak of trichinellosis with 117 cases in the Midi-Pyrenees region of France. Epidemiology, clinical features, and management., PATH BIOL, 47(5), 1999, pp. 573-575
Authors:
Pellegrin, I
Izopet, J
Reynes, J
Denayrolles, M
Montes, B
Pellegrin, JL
Massip, P
Puel, J
Fleury, H
Segondy, M
Citation: I. Pellegrin et al., Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plusdidanosine combination therapy, AIDS, 13(13), 1999, pp. 1705-1709
Authors:
Izopet, J
Bicart-See, A
Pasquier, C
Sandres, K
Bonnet, E
Marchou, B
Puel, J
Massip, P
Citation: J. Izopet et al., Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine, J MED VIROL, 59(4), 1999, pp. 507-511
Authors:
Izopet, J
Sailler, L
Sandres, K
Pasquier, C
Bonnet, E
Aquilina, C
Puel, J
Massip, P
Marchou, B
Citation: J. Izopet et al., Intermittent selection pressure with zidovudine plus zalcitabine treatmentreduces the emergence in vivo of zidovudine resistance HIV mutations, J MED VIROL, 57(2), 1999, pp. 163-168